Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Innovent Biologics
Pharma
Takeda, Innovent-Lilly, Roche—Fierce Pharma Asia
Takeda made pipeline cuts in Q3. Innovent reported a head-to-head win against semaglutide. Roche inked a respiratory bispecific deal. And more.
Angus Liu
Oct 31, 2025 8:20am
Innovent's mazdutide beats Novo's semaglutide in diabetes study
Oct 27, 2025 11:04am
Lilly-Innovent, Dizal, bispecific ADC—Fierce Pharma Asia
Jul 10, 2025 5:20pm
Lilly, Innovent's mazdutide nabs first-in-class nod in China
Jun 27, 2025 11:16am
Roche-Innovent, AstraZeneca, Viatris and more—Fierce Pharma Asia
Jan 3, 2025 8:37am
AstraZeneca, GSK, Takeda—Fierce Pharma Asia
Nov 1, 2024 8:20am
